CALCA and Pleural effusion: Novel biomarkers found in blood and pleural fluid such as procalcitonin (PCT), soluble triggering receptor expressed on myeloid cells (sTREM) and lipopolysaccharide-binding protein (LBP) have been studied to determine their clinical utility in pleural effusions with mixed and conflicting results [5–7].